Objective: To report 9 cases of en bloc kidney transplantation from pediatric donors in China and share the clinical experience. Methods: From February 2010 to February 2014, 9 pediatric donors (aged 5 months to 6 years) were assigned to us by the modern donation and allocation system after cardiac death. The en bloc kidneys were recovered in all 9 patients. The inferior vena cava and aorta of the donors were anastomosed to the external vein and artery of the recipients (7 adults and 2 children). Alprostadil or enoxaparin sodium was used for anticoagulation. Results: The kidneys attained immediate perfusion after vascular anastomosis, except for one renal artery that developed thrombosis several minutes later, necessitating nephrectomy of the unilateral graft. The other eight en bloc grafts maintained normal function during the follow-up period of 1-50 months and all the patients survived. There were no rejections or other complications. Based on ultrasonography, the grafts increased in size during the follow-up period. Conclusions: These results indicate that en bloc renal transplantation from pediatric donors is an acceptable procedure, and more widespread use could increase the number of potential donors. Splitting of pediatric donor en bloc kidneys for transplantation into two recipients may also be feasible in well-matched cases.

Keywords:
Kidney transplantation, En bloc kidney transplantation, Pediatric kidney donor, Graft outcome
1.
Wolf RA, Asbby VB, Milford EL, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaver transplant. N Engl J Med 1999;341:1725-1730.
2.
Hayes JM, Steinmuller DR, Streem SB, et al: The development of proteinuria and focal-segmental glomerulosclerosis in recipients of pediatric donor kidneys. Transplantation 1991;52:813-817.
3.
Dharnidharka VR, Stevens G, Howard RJ: En-bloc kidney transplantation in the United States: an analysis of United Network of Organ Sharing (UNOS) data from 1987 to 2003. Am J Transplant 2005;5:1513-1517.
4.
Pelletier SJ, Guidinger MK, Merion RM, et al: Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant 2006;6:1646-1652.
5.
Martin LW, Gonzalez LL, West CD, et al: Homotransplantation of both kidneys from an anencephalic monster to a 17 pound boy with Eagle-Barret syndrome. Surgery 1969;66:603-607.
6.
Thomusch O, Tittelbach-Helmrich D, Meyer S, et al: Twenty-year graft survival and graft function analysis by a matched pair study between pediatric en bloc kidney and deceased adult donors grafts. Transplantation 2009;88:920-925.
7.
Bhayana S, Kuo YF, Madan P, et al: Pediatric en bloc kidney transplantation to adult recipients: more than suboptimal. Transplantation 2010;90:248-254.
8.
Sureshkumar KK, Reddy CS, Nghiem DD, et al: Superiority of pediatric en bloc renal allografts over living donor kidneys: a long-term functional study. Transplantation 2006;82:348-353.
9.
Sharma A, Fisher RA, Cotterell AH, et al: En bloc kidney transplantation from pediatric donors: comparable outcomes with living donor kidney transplantation. Transplantation 2011;92:564-569.
10.
Khater N, Khauli R: Pseudorejection and true rejection after kidney transplantation: classification and clinical significance. Urol Int 2013;90:373-380.
11.
Zeng Y, Liu Z, Liu Y, et al: Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts. Urol Int 2014;92:328-333.
12.
Bresnahan BA, McBride MA, Cherikh WS, et al: Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of United Network for Organ Sharing data. Transplantation 2001;72:256-261.
13.
Singh A, Stablein D, Tejani A: Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997;63:1263-1267.
14.
Afanetti M, Niaudet P, Niel O, et al: Pediatric en bloc kidney transplantation into pediatric recipients: the French experience. Pediatr Transplant 2012;16:183-186.
15.
Nghiem DD, Schlosser JD, Hsia S, et al: En bloc transplantation of infant kidneys: ten-year experience. J Am Coll Surg 1998;186:402-407.
16.
Halldorson JB, Bakthavatsalam R, Salvalaggio PR, et al: Donor-recipient size matching influences early but not late graft function after pediatric en-bloc kidney transplantation. Transplantation 2010;89:208-214.
17.
Bretan PN Jr, Friese C, Goldstein RB, et al: Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys - long term experiences with 40 transplants. Transplantation 1997;63:233-237.
18.
Nghiem DD, Hsia S, Schlosser JD: Growth and function of en bloc infant kidney transplants: a preliminary study. J Urol 1995;153:326-329.
19.
Kayler LK, Magliocca J, Kim RD, et al: Single kidney transplantation from young pediatric donors in the United States. Am J Transplant 2009;9:2745-2751.
20.
Borboroglu PG, Foster CE 3rd, Philosophe B, et al: Solitary renal allografts from pediatric cadaveric donors less than 2 years of age transplanted into adult recipients. Transplantation 2004;77:698-702.
21.
Sureshkumar KK, Patel AA, Arora S, et al: When is it reasonable to split pediatric en bloc kidneys for transplantation into two adults? Transplant Proc 2010;42:3521-3523.
22.
Friedersdorff F, Fuller TF, Werthemann P, et al: Outcome of single pediatric deceased donor renal transplantation to adult kidney transplant recipients. Urol Int 2014;92:323-327.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.